Prevalence of anti-MAP3865c antibodies in T1D and T2D patients with high-risk PDR and in healthy controls.
- Antonio Pinna (630244)
- Speranza Masala (341013)
- Francesco Blasetti (630245)
- Irene Maiore (630246)
- Davide Cossu (341015)
- Daniela Paccagnini (341014)
- Giuseppe Mameli (131824)
- Leonardo A. Sechi (84079)
Publication date
September 2014
DOIAbstract
<p>Sera were tested for their reactivity against plate-coated MAP3865c<sub>261–267</sub> (A and B) and MAP3865c<sub>281–287</sub> (C and D) peptides. Antibody distribution is shown for T1D (A and C) and T2D (B and D) patients compared to controls. Data representation is the same as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0107802#pone-0107802-g001" target="_blank">Fig. 1</a>.</p
Add to ORKG